A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel.
about
Modifying Risk Factors in the Management of Erectile Dysfunction: A ReviewTestosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studiesTestosterone and weight loss: the evidence.Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study.Testosterone and obesity.The impact of age, BMI and sex hormone on aging males' symptoms and the international index of erectile function scores.Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups.Testosterone supplementation and body composition: results from a meta-analysis of observational studies.Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?Circulating sex steroids coregulate adipose tissue immune cell populations in healthy men.The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies.Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies.Relative contributions of testosterone deficiency and metabolism syndrome at the risk of reduced quality of life: A cross-sectional study among Chinese mid-aged and elderly men.Can testosterone level be a good predictor of late-onset hypogonadism?
P2860
Q26737722-DEBC58D1-1A6A-423C-BBE2-909796296DA6Q28068397-F6FCC189-0948-480F-A9D4-36F103E1CF0BQ30983590-F0E7AEBB-E7AA-434C-AD19-A6040706933FQ34134273-951E4311-4ACE-4EC0-8207-9F3AA7A03375Q34510099-BE0BF789-5A62-44ED-A66D-24DC331E9F75Q38485746-BFEAC28C-D222-44A5-AEAF-EE4FF305CAD3Q38646373-094F32AE-50D8-4284-B1A7-07E6E9A24C77Q38830965-86D21AB2-8E63-4025-A4D1-F33DA4438172Q38848541-96F019E3-6F55-4D43-A306-06013F88E752Q38997207-4FF9839B-C4B7-4236-A156-582F39D3A7DCQ46073601-875E0CE4-1D89-4E00-BE57-A3C93DA6EFB2Q47197592-3FA3213D-C4EA-41D6-926D-18C34EB536AFQ47570276-FBC66C10-8343-4C6F-AB11-013ED35513B4Q48005331-4ABF8FF4-545D-4959-B745-D2170691433CQ48078158-78484B01-DCCB-46C3-B4E6-1F1DC28FBED7
P2860
A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A 6-month observational study ...... ed with a testosterone 1% gel.
@en
A 6-month observational study ...... ed with a testosterone 1% gel.
@nl
type
label
A 6-month observational study ...... ed with a testosterone 1% gel.
@en
A 6-month observational study ...... ed with a testosterone 1% gel.
@nl
prefLabel
A 6-month observational study ...... ed with a testosterone 1% gel.
@en
A 6-month observational study ...... ed with a testosterone 1% gel.
@nl
P2093
P2860
P1433
P1476
A 6-month observational study ...... ed with a testosterone 1% gel.
@en
P2093
Alvaro Morales
Claire Pexman-Fieth
Hermann M Behre
Michael G Miller
Natalia Kan-Dobrosky
P2860
P356
10.3109/13685538.2013.858113
P577
2013-11-25T00:00:00Z